<p>(A) Representative examples of filtered OP traces from scotopic ERGs recorded before (thin traces) and after (bold traces) NMDA-induced retinal damage, in vehicle- (upper graph) or TUDCA-treated (lower graph) rats, in response to a 1 cd·s/m<sup>2</sup> stimulus (arrow). (B) Amplitude (mean ± SEM) of maximum OPs before retinal damage (pre-lesion, n = 11), and after NMDA-induced lesion in rats either treated with vehicle (NMDA, n = 5) or TUDCA (NMDA+TUDCA, n = 6). Asterisks indicate statistical significance (ANOVA, Bonferroni’s test) for pre-lesion <i>vs</i>. NMDA, and NMDA <i>vs</i>. NMDA+TUDCA groups, **P<0.01. No significant differences were found when comparing pre-lesion <i>vs</i>. NMDA+TUDCA groups.</p
<p><b>A, B:</b> Representative images of EGFP (green)-expressing microglia before (pre) or 1–7 days ...
<p>S334ter rats received an intravitreal injection of 2 µl of 20 mM Tat-µCL at PN 15 days (▪). Anoth...
<p><i>A:</i> representative traces under control conditions (left) and after (right) bath applicatio...
<p>The graph represents mixed scotopic ERG amplitude (mean ± SEM) versus stimulus intensity previous...
<p>(A) Experimental timeline indicating the days of intraperitoneal injection with TUDCA or vehicle,...
<p>(A) Percentage (mean ± SD) of surviving RGCs with respect to control (untreated, 100%), in NMDA-i...
<p>(A) Examples of ERG waves elicited by stimulus strengths rising from 0.3 to 60 cd.s/m<sup>2</sup>...
<p>(A-C) Representative ERG of wild type mice of the treatment assignment IR+NSP at baseline (before...
<p>Confocal images of whole-mounted retinas labelled with the RGC markers Brn3a (green) and RBPMS (r...
<p>(A-C) Representative ERG of tPA-/- mice of the treatment assignment IR+NSP at baseline (before IR...
<p>Effect of intraocular injection of different amounts of NMDA on Brn3a+ RGC survival. (A) Fluoresc...
<p>(A) TUNEL staining of the retina after NMDA or vehicle treatment. Scale bar, 30 μm. (B) Compariso...
<p>(A) Overlay of averaged and normalized NMDAR-EPSCs in visual cortex with or without NR2B antagoni...
<p><b>A.</b> Images of retinal cross sections (left column) and flatmounts (right 3 columns) are sho...
<p>A) Representative ERG traces. Eye-drops containing vehicle (PBS) or 1 mM Tat-µCL in saline were a...
<p><b>A, B:</b> Representative images of EGFP (green)-expressing microglia before (pre) or 1–7 days ...
<p>S334ter rats received an intravitreal injection of 2 µl of 20 mM Tat-µCL at PN 15 days (▪). Anoth...
<p><i>A:</i> representative traces under control conditions (left) and after (right) bath applicatio...
<p>The graph represents mixed scotopic ERG amplitude (mean ± SEM) versus stimulus intensity previous...
<p>(A) Experimental timeline indicating the days of intraperitoneal injection with TUDCA or vehicle,...
<p>(A) Percentage (mean ± SD) of surviving RGCs with respect to control (untreated, 100%), in NMDA-i...
<p>(A) Examples of ERG waves elicited by stimulus strengths rising from 0.3 to 60 cd.s/m<sup>2</sup>...
<p>(A-C) Representative ERG of wild type mice of the treatment assignment IR+NSP at baseline (before...
<p>Confocal images of whole-mounted retinas labelled with the RGC markers Brn3a (green) and RBPMS (r...
<p>(A-C) Representative ERG of tPA-/- mice of the treatment assignment IR+NSP at baseline (before IR...
<p>Effect of intraocular injection of different amounts of NMDA on Brn3a+ RGC survival. (A) Fluoresc...
<p>(A) TUNEL staining of the retina after NMDA or vehicle treatment. Scale bar, 30 μm. (B) Compariso...
<p>(A) Overlay of averaged and normalized NMDAR-EPSCs in visual cortex with or without NR2B antagoni...
<p><b>A.</b> Images of retinal cross sections (left column) and flatmounts (right 3 columns) are sho...
<p>A) Representative ERG traces. Eye-drops containing vehicle (PBS) or 1 mM Tat-µCL in saline were a...
<p><b>A, B:</b> Representative images of EGFP (green)-expressing microglia before (pre) or 1–7 days ...
<p>S334ter rats received an intravitreal injection of 2 µl of 20 mM Tat-µCL at PN 15 days (▪). Anoth...
<p><i>A:</i> representative traces under control conditions (left) and after (right) bath applicatio...